Sergii Melashchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergii Melashchenko has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Iryna G. Paliy
National Pirogov Memorial Medical University
5 shared publications - Oleh Ksenchyn
Vinnytsya National Pirogov Memorial Medical University, Vinnytsia, Ukraine
5 shared publications - S. O. Yatsiuk
Medical and Diagnostic Center MEDILUX Ltd, Vinnytsia, Ukraine
3 shared publications - Serhii V. Zaika
Vinnytsia National Pirogov Memorial Medical University, Vinnytsya, Ukraine
3 shared publications - Olena Voinalovych
National Pirogov Memorial Medical University
2 shared publications - Alla Kapitun
National Pirogov Memorial Medical University
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 82-91
Pilot study of the effects of a postbiotic based on Lactobacillus delbrueckii subsp. bulgaricus lysate on endotoxemia, cognitive functions, and fatigue in patients with MASLD
The objective: to evaluate the effect of a postbiotic based on Lactobacillus (L.) delbrueckii subsp. bulgaricus lysate on indicators of endotoxemia, cognitive functions, subjective fatigue, and quality of life in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Materials and methods. An open-label, pilot, single-center, prospective study with pre- and post-intervention assessment was conducted. The final analysis included 31 patients with a verified diagnosis of MASLD. All participants received a 30-day course of a postbiotic based on L. delbrueckii subsp. bulgaricus lysate. Changes in blood serum lipopolysaccharide-binding protein (LBP) concentration and fatigue severity assessed via the Fatigue Impact Scale (FIS) served as primary endpoints. Secondary endpoints included the dynamics of cognitive functions evaluated using the Animal Naming Test (ANT), and quality of life measures assessed with the EuroQol 5-Dimension 5-Level Questionnaire and the Visual Analog Scale (VAS).Results. Following the 30-day of postbiotic use a significant decrease in mean blood serum LBP level was observed (p < 0.001) with a large effect size (d = 1.63), which may indicate a reduction in endotoxemia. Cognitive functions significantly improved based on the rapid ANT results (p < 0.001; d = 0.95). Concurrently, a statistically significant reduction in the total FIS score was found (p = 0.0015; d = 0.63), accompanied by a parallel improvement in the subjective self-assessment of general health status according to the VAS (p = 0.003; d = 0.59). Structural Equation Modeling demonstrated that the association between reductions in LBP level and decreased fatigue in patients with MASLD may be partially mediated by improvements in cognitive function, whereas the direct effect remained statistically non-significant.Conclusions. In patients with MASLD, administration of a postbiotic based on a lysate of L. delbrueckii subsp. bulgaricus was associated with reductions in LBP level, improvement in cognitive function, and decreased subjective fatigue. Given the open-label uncontrolled study design, small sample size, and short follow-up period, these findings should be considered preliminary. The results obtained support further investigation into targeted modulation of the “gut-liver” axis in randomised controlled trials.
- 29 September 2026
- Published by Professional Event, LLC in Family medicine. European practices
- No. 3,p. 82-91
Open AccessPilot study of the effects of a postbiotic based on Lactobacillus delbrueckii subsp. bulgaricus lysate on endotoxemia, cognitive functions, and fatigue in patients with MASLD
The objective: to evaluate the effect of a postbiotic based on Lactobacillus (L.) delbrueckii subsp. bulgaricus lysate on indicators of endotoxemia, cognitive functions, subjective fatigue, and quality of life in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).Materials and methods. An open-label, pilot, single-center, prospective study with pre- and post-intervention assessment was conducted. The final analysis included 31 patients with a verified diagnosis of MASLD. All participants received a 30-day course of a postbiotic based on L. delbrueckii subsp. bulgaricus lysate. Changes in blood serum lipopolysaccharide-binding protein (LBP) concentration and fatigue severity assessed via the Fatigue Impact Scale (FIS) served as primary endpoints. Secondary endpoints included the dynamics of cognitive functions evaluated using the Animal Naming Test (ANT), and quality of life measures assessed with the EuroQol 5-Dimension 5-Level Questionnaire and the Visual Analog Scale (VAS).Results. Following the 30-day of postbiotic use a significant decrease in mean blood serum LBP level was observed (p < 0.001) with a large effect size (d = 1.63), which may indicate a reduction in endotoxemia. Cognitive functions significantly improved based on the rapid ANT results (p < 0.001; d = 0.95). Concurrently, a statistically significant reduction in the total FIS score was found (p = 0.0015; d = 0.63), accompanied by a parallel improvement in the subjective self-assessment of general health status according to the VAS (p = 0.003; d = 0.59). Structural Equation Modeling demonstrated that the association between reductions in LBP level and decreased fatigue in patients with MASLD may be partially mediated by improvements in cognitive function, whereas the direct effect remained statistically non-significant.Conclusions. In patients with MASLD, administration of a postbiotic based on a lysate of L. delbrueckii subsp. bulgaricus was associated with reductions in LBP level, improvement in cognitive function, and decreased subjective fatigue. Given the open-label uncontrolled study design, small sample size, and short follow-up period, these findings should be considered preliminary. The results obtained support further investigation into targeted modulation of the “gut-liver” axis in randomised controlled trials.
- Open Access
- 30 March 2026
- Published by Publishing Company VIT-A-POL in Modern Gastroenterology
- No. 1,p. 24-34
Microbiome-targeted nutritional support as factor of Helicobacter pylori eradication efficacy: results of a clinical study
Objective — to evaluate the clinical efficacy and safety profile of a multi‑strain synbiotic containing 11 bacterial strains (Lactobacillus spp., Bifidobacterium spp., Propionibacterium spp.) and enriched with prebiotics (inulin, lactulose), as part of a standard eradication quadruple therapy regimen with bismuth‑containing preparations in patients with H. pylori‑associated pathology. Materials and methods. A prospective open‑label comparative study included 109 patients with verified H. pylori infection. Participants were randomly assigned to two groups. The control group (n=61) received standard 10day quadruple therapy (proton pump inhibitor — PPI, amoxicillin, clarithromycin, bismuth subcitrate). The main group (n=48), receiving identical therapy, additionally took a multi‑strain synbiotic containing 11 bacterial strains (Lactobacillus spp., Bifidobacterium spp., Propionibacterium spp.) enriched with prebiotics (inulin, lactulose), 1 capsule twice daily for 15 days (eradication course + 5 days). Symptom assessment was performed using the Gastrointestinal Symptom Rating Scale (GSRS). Eradication control was conducted 4 weeks after treatment completion. The statistical analysis involved calculating the number of patients who need to be treated (Number Needed to Treat (NNT)) and the relative risk reduction (RRR) of treatment failure, as well as constructing a logistic regression model. Results. Protocol analysis showed that the successful eradication rate in the main group reached 87.5% (42/48), which was significantly higher than in the control group — 65.6% (40/61) (p<0.05). The addition of the synbiotic provided a Relative Risk Reduction (RRR) of treatment failure by 63.7%; the Number Needed to Treat (NNT) was 4.6. According to the GSRS scale, the main group showed significantly lower intensity of diarrhea syndrome (1.42±0.14 points vs. 1.88±0.17 in control; p 85%), significantly reducing the risk of treatment failure, and improving tolerability by preventing antibiotic‑associated disorders.
- 30 March 2026
- Published by Publishing Company VIT-A-POL in Modern Gastroenterology
- No. 1,p. 24-34
Open AccessMicrobiome-targeted nutritional support as factor of Helicobacter pylori eradication efficacy: results of a clinical study
Objective — to evaluate the clinical efficacy and safety profile of a multi‑strain synbiotic containing 11 bacterial strains (Lactobacillus spp., Bifidobacterium spp., Propionibacterium spp.) and enriched with prebiotics (inulin, lactulose), as part of a standard eradication quadruple therapy regimen with bismuth‑containing preparations in patients with H. pylori‑associated pathology. Materials and methods. A prospective open‑label comparative study included 109 patients with verified H. pylori infection. Participants were randomly assigned to two groups. The control group (n=61) received standard 10day quadruple therapy (proton pump inhibitor — PPI, amoxicillin, clarithromycin, bismuth subcitrate). The main group (n=48), receiving identical therapy, additionally took a multi‑strain synbiotic containing 11 bacterial strains (Lactobacillus spp., Bifidobacterium spp., Propionibacterium spp.) enriched with prebiotics (inulin, lactulose), 1 capsule twice daily for 15 days (eradication course + 5 days). Symptom assessment was performed using the Gastrointestinal Symptom Rating Scale (GSRS). Eradication control was conducted 4 weeks after treatment completion. The statistical analysis involved calculating the number of patients who need to be treated (Number Needed to Treat (NNT)) and the relative risk reduction (RRR) of treatment failure, as well as constructing a logistic regression model. Results. Protocol analysis showed that the successful eradication rate in the main group reached 87.5% (42/48), which was significantly higher than in the control group — 65.6% (40/61) (p<0.05). The addition of the synbiotic provided a Relative Risk Reduction (RRR) of treatment failure by 63.7%; the Number Needed to Treat (NNT) was 4.6. According to the GSRS scale, the main group showed significantly lower intensity of diarrhea syndrome (1.42±0.14 points vs. 1.88±0.17 in control; p 85%), significantly reducing the risk of treatment failure, and improving tolerability by preventing antibiotic‑associated disorders.
- Open Access
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 96-105
Adherence of primary care providers to implementing recommendations for the diagnosis and treatment of Helicobacter pylori-associated dyspepsia: survey results
Background. A few studies that have examined a general practitioners’ (GPs) adherence to guidelines on the management of Helicobacter pylori (Hp)-associated diseases indicate poor quality of care for this common population group in various parts of the world. In Ukraine, this issue has not been investigated until now. Aim: to study the GP’s adherence to contemporary guidelines on the management of patients with dyspepsia, including the unified clinical protocols for primary care in dyspepsia and peptic ulcer approved by the Ministry of Health of Ukraine. Materials and methods. A survey of 132 GPs was conducted using the MS Forms online questionnaire. It included 3 clinical cases with typical clinical manifestations of dyspepsia associated with Hp infection. It was proposed to determine the list of appropriate tests for primary and final Hp diagnosis, as well as to select adequate eradication regimens from 8 patterns. Results. The most popular methods for primary Hp diagnosis were as follows: the determination of fecal antigen to Hp (51.5 % of respondents); 13C-urea breath test (50 % of respondents); and the rapid urease test during upper esophagogastroduodenoscopy (38.6 % of respondents). However, 7.6 % of GPs incorrectly recommended the ammonia breath test; 8.3 % of GPs incorrectly opted for IgM testing instead of total serum antibody assessment. Moreover, despite the absence of “red flag symptoms” in the provided clinical cases, 36.4 % of respondents suggested upper endoscopy and other unnecessary tests in case of a positive Hp-test. Only 1.5 % proposed a progressive approach of determining Hp sensitivity to clarithromycin by the polymerase chain reaction. 43.9 % of GPs selected the correct Hp eradication regimens, whilst taking into account the hypothesised high prevalence of primary antibiotic resistance in Ukraine. 14.4 % of respondents chose both adequate and inadequate regimens. 40 % of GPs confused primary and secondary therapy or were limited to prescribing standard triple therapy. Among family doctors, the prescription of probiotics in combination with eradication is popular (55.3 %). In 42 % of cases with a persistence of dyspeptic symptoms after successful eradication of Hp, GPs referred patients to secondary care specialists, and 43 % attempted to manage this on their own, by prescribing adequate imaging tests and symptomatic therapy. 13 % of GPs . This survey revealed insufficient adherence to current guidelines on the diagnosis and treatment of Hp-infection among the GPs from the Vinnytsia region, which generally coincides with the situation in other countries. Improvements in the system of continuing medical education alongside realistic motivational mechanisms are promising.
- 27 June 2025
- Published by Publishing House Zaslavsky in GASTROENTEROLOGY
- Vol. 59 (2) , 96-105
Open AccessAdherence of primary care providers to implementing recommendations for the diagnosis and treatment of Helicobacter pylori-associated dyspepsia: survey results
Background. A few studies that have examined a general practitioners’ (GPs) adherence to guidelines on the management of Helicobacter pylori (Hp)-associated diseases indicate poor quality of care for this common population group in various parts of the world. In Ukraine, this issue has not been investigated until now. Aim: to study the GP’s adherence to contemporary guidelines on the management of patients with dyspepsia, including the unified clinical protocols for primary care in dyspepsia and peptic ulcer approved by the Ministry of Health of Ukraine. Materials and methods. A survey of 132 GPs was conducted using the MS Forms online questionnaire. It included 3 clinical cases with typical clinical manifestations of dyspepsia associated with Hp infection. It was proposed to determine the list of appropriate tests for primary and final Hp diagnosis, as well as to select adequate eradication regimens from 8 patterns. Results. The most popular methods for primary Hp diagnosis were as follows: the determination of fecal antigen to Hp (51.5 % of respondents); 13C-urea breath test (50 % of respondents); and the rapid urease test during upper esophagogastroduodenoscopy (38.6 % of respondents). However, 7.6 % of GPs incorrectly recommended the ammonia breath test; 8.3 % of GPs incorrectly opted for IgM testing instead of total serum antibody assessment. Moreover, despite the absence of “red flag symptoms” in the provided clinical cases, 36.4 % of respondents suggested upper endoscopy and other unnecessary tests in case of a positive Hp-test. Only 1.5 % proposed a progressive approach of determining Hp sensitivity to clarithromycin by the polymerase chain reaction. 43.9 % of GPs selected the correct Hp eradication regimens, whilst taking into account the hypothesised high prevalence of primary antibiotic resistance in Ukraine. 14.4 % of respondents chose both adequate and inadequate regimens. 40 % of GPs confused primary and secondary therapy or were limited to prescribing standard triple therapy. Among family doctors, the prescription of probiotics in combination with eradication is popular (55.3 %). In 42 % of cases with a persistence of dyspeptic symptoms after successful eradication of Hp, GPs referred patients to secondary care specialists, and 43 % attempted to manage this on their own, by prescribing adequate imaging tests and symptomatic therapy. 13 % of GPs . This survey revealed insufficient adherence to current guidelines on the diagnosis and treatment of Hp-infection among the GPs from the Vinnytsia region, which generally coincides with the situation in other countries. Improvements in the system of continuing medical education alongside realistic motivational mechanisms are promising.
- Open Access
- 6 June 2025
- Published by Publishing Company VIT-A-POL in Modern Gastroenterology
- No. 2,p. 14-24
Everyday stereotypes of general practitioners in management of patients with dyspeptic complaints: results of computer survey
Limited studies examining general practitioners’ (GPs) adherence to guidelines for managing dyspepsia indicate insufficient quality of care for this population group in various parts of the world. In Ukraine, this issue has not been studied until now. Objective — to examine the adherence of GPs to contemporary recommendations for managing patients with dyspepsia, including the 2020 Clinical Guidelines of the Ukrainian Gastroenterological Association. Materials and methods. A survey of 132 GPs was conducted using an online MS Forms questionnaire. It included 3 clinical cases with typical clinical manifestations of postprandial distress syndrome (PDS), epigastric pain syndrome (EPS), and overlap of both subtypes (PDS/EPS). Respondents were asked to determine the clinical diagnosis, list relevant tests, and prescribe preliminary pharmacological therapy with an unlimited choice of drugs. Two independent experts evaluated the responses. Results. The correct provisional diagnoses for all cases were «uninvestigated dyspepsia» or «functional dyspepsia», chosen in 46.23% of responses. Doctors slightly favored «uninvestigated dyspepsia». The dyspepsia subtype was correctly identified by 47% of respondents for PDS, 70% for EPS, and 56% for the overlap of PDS/EPS. Despite the absence of alarm symptoms and the patients being younger than 40 years, 76.2% of GPs recommended upper endoscopy. This can be attributed to the heightened awareness of stomach cancer, which has a high incidence rate in Ukraine. Other tests (general blood test, ultrasound examination) were prescribed appropriately, with 77.2% of respondents suggesting Helicobacter pylori testing. Ideal symptomatic therapy included prescribing a proton pump inhibitor (PPI) or an H2‑receptor antagonist for EPS and prokinetics for PDS. In cases of overlap, both drug types are required. This paradigm was followed by 14.1% of respondents. Additionally, 21.5% of doctors suggested an acceptable regimen involving only potent secretion inhibitors without prokinetics for PDS. The most common mistakes were polypharmacy, prescribing myotropic antispasmodics, and empirically eradicating H. pylori. Conclusions. This survey revealed insufficient adherence to current recommendations for diagnosing, testing, and treating dyspepsia among GPs in the Vinnytsia region, mirroring the situation in other countries. Real improvements could be achieved by creating simplified guidelines targeted at primary care providers, approved by the Ministry of Health of Ukraine as official departmental instructions. There is a need for improving the Continuing Medical Education system, incorporating real motivational mechanisms.
- 6 June 2025
- Published by Publishing Company VIT-A-POL in Modern Gastroenterology
- No. 2,p. 14-24
Open AccessEveryday stereotypes of general practitioners in management of patients with dyspeptic complaints: results of computer survey
Limited studies examining general practitioners’ (GPs) adherence to guidelines for managing dyspepsia indicate insufficient quality of care for this population group in various parts of the world. In Ukraine, this issue has not been studied until now. Objective — to examine the adherence of GPs to contemporary recommendations for managing patients with dyspepsia, including the 2020 Clinical Guidelines of the Ukrainian Gastroenterological Association. Materials and methods. A survey of 132 GPs was conducted using an online MS Forms questionnaire. It included 3 clinical cases with typical clinical manifestations of postprandial distress syndrome (PDS), epigastric pain syndrome (EPS), and overlap of both subtypes (PDS/EPS). Respondents were asked to determine the clinical diagnosis, list relevant tests, and prescribe preliminary pharmacological therapy with an unlimited choice of drugs. Two independent experts evaluated the responses. Results. The correct provisional diagnoses for all cases were «uninvestigated dyspepsia» or «functional dyspepsia», chosen in 46.23% of responses. Doctors slightly favored «uninvestigated dyspepsia». The dyspepsia subtype was correctly identified by 47% of respondents for PDS, 70% for EPS, and 56% for the overlap of PDS/EPS. Despite the absence of alarm symptoms and the patients being younger than 40 years, 76.2% of GPs recommended upper endoscopy. This can be attributed to the heightened awareness of stomach cancer, which has a high incidence rate in Ukraine. Other tests (general blood test, ultrasound examination) were prescribed appropriately, with 77.2% of respondents suggesting Helicobacter pylori testing. Ideal symptomatic therapy included prescribing a proton pump inhibitor (PPI) or an H2‑receptor antagonist for EPS and prokinetics for PDS. In cases of overlap, both drug types are required. This paradigm was followed by 14.1% of respondents. Additionally, 21.5% of doctors suggested an acceptable regimen involving only potent secretion inhibitors without prokinetics for PDS. The most common mistakes were polypharmacy, prescribing myotropic antispasmodics, and empirically eradicating H. pylori. Conclusions. This survey revealed insufficient adherence to current recommendations for diagnosing, testing, and treating dyspepsia among GPs in the Vinnytsia region, mirroring the situation in other countries. Real improvements could be achieved by creating simplified guidelines targeted at primary care providers, approved by the Ministry of Health of Ukraine as official departmental instructions. There is a need for improving the Continuing Medical Education system, incorporating real motivational mechanisms.
- Open Access
- 20 March 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 3,p. 104-112
PREVALENCE OF GASTROINTESTINAL SYMPTOMS AMONG ENGLISH-SPEAKING STUDENTS IN THE CONTEXT OF EXPOSURE TO LEADING RISK FACTORS
Introduction. Hypodynamia and associated obesity, depression, and anxiety are recognized risk factors for numerous diseases of the digestive tract. Studying their impact on the young population is a particularly urgent task, given the spread of online learning and the increase in psychological stress induced by the Russian military invasion of Ukraine in recent years. Aim. To study the influence of the above-mentioned risk factors on the appearance of the gastrointestinal symptoms. Materials and methods. A survey of 208 English-speaking medical students was performed. It included 3 questionnaires: Gastrointestinal Symptom Rating Scale (GSRS), International Physical Activity Questionnaire (IPAQ), and Hospital Anxiety and Depression Scale (HADS). Body weight, height, alcohol consumption, and smoking habits were also estimated. Results. 62% of students reported troublesome complaints greater than “minor discomfort” at least in one of the GSRS clusters. The total number of points on the GSRS, as well as in the clusters “abdominal pain” (AP), “reflux” (RS), “indigestion” (IS), “diarrhea” (DS) and “constipation” (CS), were significantly correlated with the severity of anxiety (r = 0.14 to 0.19) but not depression. Alcohol consumption, expressed in three stipulated levels, also increased scores in all clusters except RS and CS. A higher MET-parameter of IPAQ was associated with reduced symptoms in the RS cluster. Only 36.5% of students didn’t experience anxiety, and 24.5% didn’t experience depression. Seasonality of these syndromes was observed: the average anxiety score (Mean±SEM) in winter was 9.10±0.23 points versus 7.20±0.56 points in summer; for depression, it was 12.36±0.18 versus 6.21±0.48, respectively (p<0.05). To identify the risk factors of gastrointestinal symptoms, a logistic regression analysis was performed using four predictor variables that demonstrated a significant association in preliminary assessments. Conclusions. Independent predictors (risk factors) of troublesome gastrointestinal symptoms in the studied population include intense anxiety (HADS score), low levels of physical activity (MET parameter), female gender, and the winter season. Depression is associated with concomitant anxiety and the winter season but is not directly related to gastrointestinal complaints.
- 20 March 2025
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 3,p. 104-112
Open AccessPREVALENCE OF GASTROINTESTINAL SYMPTOMS AMONG ENGLISH-SPEAKING STUDENTS IN THE CONTEXT OF EXPOSURE TO LEADING RISK FACTORS
Introduction. Hypodynamia and associated obesity, depression, and anxiety are recognized risk factors for numerous diseases of the digestive tract. Studying their impact on the young population is a particularly urgent task, given the spread of online learning and the increase in psychological stress induced by the Russian military invasion of Ukraine in recent years. Aim. To study the influence of the above-mentioned risk factors on the appearance of the gastrointestinal symptoms. Materials and methods. A survey of 208 English-speaking medical students was performed. It included 3 questionnaires: Gastrointestinal Symptom Rating Scale (GSRS), International Physical Activity Questionnaire (IPAQ), and Hospital Anxiety and Depression Scale (HADS). Body weight, height, alcohol consumption, and smoking habits were also estimated. Results. 62% of students reported troublesome complaints greater than “minor discomfort” at least in one of the GSRS clusters. The total number of points on the GSRS, as well as in the clusters “abdominal pain” (AP), “reflux” (RS), “indigestion” (IS), “diarrhea” (DS) and “constipation” (CS), were significantly correlated with the severity of anxiety (r = 0.14 to 0.19) but not depression. Alcohol consumption, expressed in three stipulated levels, also increased scores in all clusters except RS and CS. A higher MET-parameter of IPAQ was associated with reduced symptoms in the RS cluster. Only 36.5% of students didn’t experience anxiety, and 24.5% didn’t experience depression. Seasonality of these syndromes was observed: the average anxiety score (Mean±SEM) in winter was 9.10±0.23 points versus 7.20±0.56 points in summer; for depression, it was 12.36±0.18 versus 6.21±0.48, respectively (p<0.05). To identify the risk factors of gastrointestinal symptoms, a logistic regression analysis was performed using four predictor variables that demonstrated a significant association in preliminary assessments. Conclusions. Independent predictors (risk factors) of troublesome gastrointestinal symptoms in the studied population include intense anxiety (HADS score), low levels of physical activity (MET parameter), female gender, and the winter season. Depression is associated with concomitant anxiety and the winter season but is not directly related to gastrointestinal complaints.
- Open Access
- 1 January 2020
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 15 (3) , 258-266
Assessment of gastric acidity by short-duration intragastric pH-monitoring with standardised breakfast in functional and some other dyspepsias
Introduction Preliminary assessment of gastric secretion in the treatment of organic and functional dyspepsia may offer advantages over the empirical administration of proton pump inhibitors suggested by most clinical guidelines. Aim To develop a simplified pH-metric test with standardised...
- 1 January 2020
- Published by Termedia Sp. z.o.o. in Gastroenterology Review
- Vol. 15 (3) , 258-266
Open AccessAssessment of gastric acidity by short-duration intragastric pH-monitoring with standardised breakfast in functional and some other dyspepsias
Introduction Preliminary assessment of gastric secretion in the treatment of organic and functional dyspepsia may offer advantages over the empirical administration of proton pump inhibitors suggested by most clinical guidelines. Aim To develop a simplified pH-metric test with standardised...